Not available
Quote | bluebird bio Inc. (NASDAQ:BLUE)
Last: | $0.9478 |
---|---|
Change Percent: | 2.16% |
Open: | $0.998 |
Close: | $0.9478 |
High: | $1.01 |
Low: | $0.9475 |
Volume: | 5,741,465 |
Last Trade Date Time: | 06/25/2024 03:00:00 am |
News | bluebird bio Inc. (NASDAQ:BLUE)
The recent 4-year partnership between Pfizer and Beam Therapeutics involves $300 million upfront to speed validation of the technology and an additional $1.05 billion in milestone payments. A recent amended agreement between Verve Therapeutics and Beam Therapeutics is a target swap th...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...
Message Board Posts | bluebird bio Inc. (NASDAQ:BLUE)
Subject | By | Source | When |
---|---|---|---|
I have a similar position - 98,050 in | Moose412 | investorshub | 04/27/2023 7:08:18 AM |
FYI | stocksrising | investorshub | 04/24/2023 11:53:50 AM |
Here is an example from a few accounts | stocksrising | investorshub | 04/20/2023 11:46:16 AM |
You picked up 90k shares since September? | Moose412 | investorshub | 04/20/2023 8:33:02 AM |
I have ~100,000 reasons why Im hoping | stocksrising | investorshub | 04/18/2023 9:52:26 PM |
News, Short Squeeze, Breakout and More Instantly...
The downtrodden biotech space has kicked off the second half of 2022 with a boom. Hard-hit gene-editing and gene therapy companies in particular have started the back half of the year on the right foot. Underscoring this point, Bluebird Bio (NASDAQ: BLUE) stock has already risen by ...
Bluebird Bio 's (NASDAQ: BLUE) stock motored upward above 24% amid an unusually high volume of trading before pulling back to around 13.3% by noon on Tuesday, likely as a result of a short squeeze . More than 34.6% of its floating shares were held short as of June 15, which puts...